Health

Scratch where it itches - An International-Gold-Medal-Winning Canine Allergen Test Kit by Chula Veterinary Science Lecturer

BANGKOK, Aug. 9, 2023 /PRNewswire/ -- Chula Veterinary Science Lecturers have successfully developed a Serum Test Kit to Identify Canine Atopic Dermatitis(CAD )caused by dust mites.  With a Gold Medal from the Swiss Innovation Contest, the test kit is guaranteed to help identify the allergens with...

2023-08-09 10:00 2367

Everest Medicines to Announce First Half 2023 Financial Results on August 24, 2023

SHANGHAI, Aug. 9, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that it will report financial results for the fir...

2023-08-09 08:06 2114

Lynk Pharmaceuticals Announced Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Atopic Dermatitis

HANGZHOU, China, Aug. 9, 2023 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced positive topline data from a Phase II clinical trial of LNK01001 for the treatment of atopic dermatitis. The study was...

2023-08-09 08:00 2947

Race Strategic Update August 2023

SYDNEY, Aug. 9, 2023 /PRNewswire/ -- Race Oncology Limited ("Race") is pleased to provide a strategic update, including an overview of revisions to corporate strategy, designed to optimise use of existing resources, while driving bisantrene's commercial partnering and collaboration potential. Ev...

2023-08-09 07:30 2747

Neuragenex Expands to Open New Illinois Location, Giving More People Access to its Innovative Approach to Chronic Pain Management

CHICAGO, Aug. 8, 2023 /PRNewswire/ -- Neuragenex, a trailblazing pain management practice at the forefront of pain management solutions, is delighted to announce the opening of four new locations inIllinois. With its groundbreaking approach to chronic pain management that is drug-free and non-in...

2023-08-09 00:14 1280

Neuragenex Expands to Open New Utah Location, Giving More People Access to its Innovative Approach to Chronic Pain Management

SALT LAKE CITY, Aug. 8, 2023 /PRNewswire/ -- Neuragenex, a trailblazing pain management practice at the forefront of pain management solutions, is delighted to announce the opening ofBluffdale and Lehi clinic locations in Utah. With its groundbreaking approach to chronic pain management that is d...

2023-08-09 00:13 1333

Neuragenex Expands to Open New Georgia Locations, Giving More People Access to its Innovative Approach to Chronic Pain Management

ATLANTA, Aug. 8, 2023 /PRNewswire/ -- Neuragenex, a trailblazing pain management practice at the forefront of pain management solutions, is delighted to announce the opening of theLawrenceville clinic location in Georgia. With its groundbreaking approach to chronic pain management that is drug-fr...

2023-08-09 00:13 1301

Neuragenex Expands to Open New Texas Location, Giving More People Access to its Innovative Approach to Chronic Pain Management

VICTORIA and WACO, Texas, Aug. 8, 2023 /PRNewswire/ -- Neuragenex, a trailblazing pain management practice at the forefront of pain management solutions, is delighted to announce the opening of theWaco and Victoria clinic locations inTexas. With its groundbreaking approach to chronic pain managem...

2023-08-09 00:03 1344

MomMed S21 Breast Pump Receives Three Prestigious Industry Awards

-  The Choice of Modern Moms: MomMed Breast Pump Stands Out in the Market NEW YORK, Aug. 8, 2023 /PRNewswire/ -- MomMed , a renowned mother and baby brand, proudly announces that its flagship product, the S21 Breast Pump, has received three prestigious industry awards in 2023...

2023-08-08 21:00 1555

Vatech Announces Distribution Through Henry Schein to Help Oral Health Professionals Enhance Access to Cutting-Edge Imaging Solutions

HWASEONG, South Korea, Aug. 8, 2023 /PRNewswire/ -- Vatech, a global leader in the dental imaging market, has announced that its products will be distributed byHenry Schein, helping to expand the availability of its cutting-edge products for dental clinics inNorth America. Vatech's portfolio o...

2023-08-08 21:00 1639

SPARK™ CLEAR ALIGNERS ANNOUNCES KEY CLINICAL UPDATES & DOCTOR-DRIVEN INNOVATIONS IN RELEASE 14

– Comprehensive Technology and Clinical Improvements Continue to Support the Treatment of Orthodontic Patients – BREA, Calif., Aug. 8, 2023 /PRNewswire/ -- Ormco Corporation announces the highly anticipated Spark Clear Aligners Release 14.  Release 14 continues Spark's philosophy of giving ortho...

2023-08-08 20:45 1909

I-Mab to Report Mid-Year 2023 Financial Results, Business and Corporate Updates on August 17, 2023

ROCKVILLE, Md. and SHANGHAI, Aug. 8, 2023 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of pioneering immunotherapies, today announced that it will report business and corporate updat...

2023-08-08 20:00 1621

For those who are worried about bad breath, "Wedent" is released

Even the "Wedent" tongue cleaner function, where hygiene and safety are the top priority! SEOUL, South Korea, Aug. 8, 2023 /PRNewswire/ -- Wedent, which has developed and produced only the best oral care products to lead a healthy oral culture since its establishment in 2001, was finally selecte...

2023-08-08 20:00 1536

ALPINION Launches a High-Performance Portable Ultrasound Diagnostic Device, X-CUBE i9

SEOUL, South Korea, Aug. 8, 2023 /PRNewswire/ -- ALPINION MEDICAL SYSTEMS Co., Ltd. launched 'X-CUBE i9', a portable ultrasound diagnostic device, with dual batteries and probe connectors that has greatly enhanced the speed and efficiency of examinations.

2023-08-08 17:03 2111

Waterdrop Inc. Advances Sustainable Development with Completion of UN's Climate Ambition Accelerator Training

BEIJING, Aug. 8, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, recently completed the United Nations Global Compact's Climate Ambition Accelerator (C...

2023-08-08 16:25 3960

Harbour BioMed Appoints Dr. Albert R. Collinson as Independent Non-Executive Director

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Aug. 8, 2023 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunolo...

2023-08-08 16:10 2656

Herbalife Releases Second Global Sustainability Report

New Report Underscores the Global Health and Wellness Company's Commitments to Product, People and Planet HONG KONG, Aug. 8, 2023 /PRNewswire/ -- Premier health and wellness company, Herbalife, has released its second Global Sustainability Report: Live Your Best Life. The report covers the impac...

2023-08-08 15:00 5607

Innovent Announces the Preclinical Results of IBI363 (PD-1/IL-2 Bispecific Antibody Fusion Protein) were Published in Nature Cancer

ROCKVILLIE, Md. and SUZHOU, China, Aug. 8, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...

2023-08-08 11:03 2679

Pfizer Malaysia, Sunway Medical Centre Velocity and Sunway Multicare Pharmacy Collaborate to Raise Awareness on the Importance of Early Detection of Atrial Fibrillation

KUALA LUMPUR, Malaysia, Aug. 8, 2023 /PRNewswire/ -- Pfizer Malaysia, Sunway Medical Centre Velocity and Sunway Multicare Pharmacy, have entered a tripartite collaboration on AF360, a program highlighting the importance of early detection of Atrial Fibrillation (AF). AF is a devastating heart dis...

2023-08-08 09:00 1743

First Patient Dosed in IPAX-2 Study of TLX101 Brain Cancer Therapy Candidate in Patients with Newly Diagnosed Glioblastoma

MELBOURNE, Australia, Aug. 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in a Phase I study of the Company's investigational therapy TLX101 (4-L-[131I] iodo-phenylalanine, or 131I-IPA) in combination with p...

2023-08-08 06:24 1885
1 ... 182183184185186187188 ... 847